none9noanoneBASSETTI, MATTEO; Ansaldi, Filippo; De Florentiis, Daniela; Righi, Elda; Pea, Federico; Sartor, Assunta; Scarparo, Claudio; Carnelutti, Alessia; PEA, FedericoBASSETTI, MATTEO; Ansaldi, Filippo; De Florentiis, Daniela; Righi, Elda; Pea, Federico; Sartor, Assunta; Scarparo, Claudio; Carnelutti, Alessia; PEA, Federic
Daptomycin is a cyclic lipopeptide with potent bactericidal activity against Gram-positive organisms...
Methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia is a serious infection resulting in 2...
Background: Bacteremia caused by methicillin-resistant Staphylococcus aureus is associated with inc...
Appropriate empiric therapy, antibiotic therapy with in vitro activity to the infecting organism giv...
BACKGROUND: Alternative therapies for Staphylococcus aureus bacteremia and endocarditis are needed. ...
Objectives: Recent studies have shown that methicillin-resistantStaphylococcus aureus (MRSA) bactera...
Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis: an in vitro and ...
Background: Endocarditis and bacteraemia are devastating infections with high mortality. Gram-positi...
Mortality rate in methicillin-resistant staphylococcus aureus (MRSA) bacteraemia ranges from 13% to ...
Define prevalence, morbidity, and mortality associated with Staphylococcus aureus infections Describ...
Daptomycin is inactivated by pulmonary surfactant, but its effectiveness in hematogenous pulmonary i...
Abstract Background Staphylococcus aureus bacteremia is associated with significant morbidity and mo...
Complicated Staphylococcus aureus infections, including bacteremia, are often associated with treatm...
Importance Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia is associated with mortali...
Introduction: Daptomycin, a novel lipopeptide antibiotic, has been introduced recently to clinical u...
Daptomycin is a cyclic lipopeptide with potent bactericidal activity against Gram-positive organisms...
Methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia is a serious infection resulting in 2...
Background: Bacteremia caused by methicillin-resistant Staphylococcus aureus is associated with inc...
Appropriate empiric therapy, antibiotic therapy with in vitro activity to the infecting organism giv...
BACKGROUND: Alternative therapies for Staphylococcus aureus bacteremia and endocarditis are needed. ...
Objectives: Recent studies have shown that methicillin-resistantStaphylococcus aureus (MRSA) bactera...
Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis: an in vitro and ...
Background: Endocarditis and bacteraemia are devastating infections with high mortality. Gram-positi...
Mortality rate in methicillin-resistant staphylococcus aureus (MRSA) bacteraemia ranges from 13% to ...
Define prevalence, morbidity, and mortality associated with Staphylococcus aureus infections Describ...
Daptomycin is inactivated by pulmonary surfactant, but its effectiveness in hematogenous pulmonary i...
Abstract Background Staphylococcus aureus bacteremia is associated with significant morbidity and mo...
Complicated Staphylococcus aureus infections, including bacteremia, are often associated with treatm...
Importance Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia is associated with mortali...
Introduction: Daptomycin, a novel lipopeptide antibiotic, has been introduced recently to clinical u...
Daptomycin is a cyclic lipopeptide with potent bactericidal activity against Gram-positive organisms...
Methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia is a serious infection resulting in 2...
Background: Bacteremia caused by methicillin-resistant Staphylococcus aureus is associated with inc...